These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 25467043

  • 41. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?
    Grynberg M, Labrosse J, Bennani Smires B, Sifer C, Peigne M, Sonigo C.
    Hum Reprod; 2021 Jun 18; 36(7):1941-1947. PubMed ID: 34037751
    [Abstract] [Full Text] [Related]

  • 42. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA, Lee AY, Grogan TR, Abbott DH, Largaespada K, Chazenbalk GD, Dumesic DA.
    Fertil Steril; 2018 Mar 18; 109(3):508-515. PubMed ID: 29428312
    [Abstract] [Full Text] [Related]

  • 43. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
    Pearce K, Gleeson K, Tremellen K.
    Hum Reprod; 2015 Sep 18; 30(9):2171-7. PubMed ID: 26202912
    [Abstract] [Full Text] [Related]

  • 44. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K, Zander-Fox D.
    Aust N Z J Obstet Gynaecol; 2015 Aug 18; 55(4):384-9. PubMed ID: 26230428
    [Abstract] [Full Text] [Related]

  • 45. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
    Vural F, Vural B, Kardaş E, Ertürk Coşkun AD, Yildirim İ.
    Arch Gynecol Obstet; 2023 Apr 18; 307(4):1083-1090. PubMed ID: 36565362
    [Abstract] [Full Text] [Related]

  • 46. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
    Sahmay S, Guralp O, Aydogan B, Cepni I, Oral E, Irez T.
    Gynecol Endocrinol; 2013 May 18; 29(5):440-3. PubMed ID: 23461296
    [Abstract] [Full Text] [Related]

  • 47. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S.
    Hum Reprod; 2019 Dec 01; 34(12):2467-2479. PubMed ID: 31735954
    [Abstract] [Full Text] [Related]

  • 48. Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C).
    Pankhurst MW, Shorakae S, Rodgers RJ, Teede HJ, Moran LJ.
    Fertil Steril; 2017 Nov 01; 108(5):851-857.e2. PubMed ID: 29079276
    [Abstract] [Full Text] [Related]

  • 49. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Acta Obstet Gynecol Scand; 2015 Mar 01; 94(3):279-87. PubMed ID: 25545309
    [Abstract] [Full Text] [Related]

  • 50. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ, Stojanovic N, Dewailly D.
    Hum Reprod; 2018 Jun 01; 33(6):1141-1148. PubMed ID: 29688494
    [Abstract] [Full Text] [Related]

  • 51. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN.
    Hum Reprod; 2008 Apr 01; 23(4):952-7. PubMed ID: 18256110
    [Abstract] [Full Text] [Related]

  • 52. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW, Bentzen JG, Thuesen LL, Lauritsen MP, Forman JL, Loft A, Pinborg A, Nyboe Andersen A.
    Hum Reprod; 2016 May 01; 31(5):1034-45. PubMed ID: 26965431
    [Abstract] [Full Text] [Related]

  • 53. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA.
    Hum Reprod; 2020 Oct 01; 35(10):2294-2302. PubMed ID: 32918081
    [Abstract] [Full Text] [Related]

  • 54. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 55. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 56. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D.
    Gynecol Endocrinol; 2013 Jun 01; 29(6):545-50. PubMed ID: 23506275
    [Abstract] [Full Text] [Related]

  • 57. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G, Gallo C, Catteau-Jonard S, Lefebvre-Maunoury C, Pigny P, Duhamel A, Dewailly D.
    J Clin Endocrinol Metab; 2012 Nov 01; 97(11):4236-43. PubMed ID: 22948766
    [Abstract] [Full Text] [Related]

  • 58. Cut-off value for anti-Müllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population.
    Noguchi H, Iwasa T, Iwase A, Kanasaki H, Kimura F, Kugu K, Saito K, Baba T, Hara T, Matsuzaki T.
    J Obstet Gynaecol Res; 2024 Aug 01; 50(8):1368-1382. PubMed ID: 38831323
    [Abstract] [Full Text] [Related]

  • 59. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome.
    Yang JH, Chou CH, Yang WS, Ho HN, Yang YS, Chen MJ.
    Taiwan J Obstet Gynecol; 2015 Dec 01; 54(6):686-92. PubMed ID: 26700986
    [Abstract] [Full Text] [Related]

  • 60. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T, Munkhzaya M, Iwasa T, Tungalagsuvd A, Yano K, Mayila Y, Yanagihara R, Tokui T, Kato T, Kuwahara A, Matsui S, Irahara M.
    Endocr J; 2017 May 30; 64(5):531-541. PubMed ID: 28381699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.